Pfizer Buying Cardiovascular Biopharma Company
National Pulse Pfizer is about to buy Arena Pharmaceuticals for $6.7 billion. Arena is a biopharmaceutical company focused in part on cardiovascular and inflammatory medicines to a global patient cohort. [Read More]